Tags
trial
Latest Tag News
-
Galapagos Experimental Bowl Drug Fails to Meet Phase II Mark
By Cheri Cheng | Jan 26, 2016 09:22 AM ESTGalapagos NV announced that its experimental drug for bowel disease did not meet a significant Phase II mark.
-
A Failed Drugs Trial in France Left One Dead And Five Hospitalized
By Mara Mayer | Jan 20, 2016 08:52 AM ESTA French criminal investigation is underway following a failed drugs trial for Portuguese drug company Bial that resulted in one confirmed death and five serious hospitalizations.
-
Experimental French Drug Leaves One Brain Dead, Five in Serious Condition
By Cheri Cheng | Jan 15, 2016 09:27 AM ESTAn experimental drug has left one participant brain dead and five others in critical condition, the French health ministry stated.
-
Treating At-Risk People with Normal Blood Pressure can Save Lives, Study Finds
By Cheri Cheng | Dec 24, 2015 09:35 AM ESTPeople who are considered to be at-risk of heart attack and stroke should get blood pressure treatment even if their levels are normal, a new study is reporting.
-
Second Participant in Zafgen’s Obesity Drug Trial Dies
By Cheri Cheng | Dec 02, 2015 04:09 PM ESTA second participant involved in Zafgen's late phase trial for an obesity drug has died.
-
Novartis’s Drug for Hard-to-Treat MS Fails
By Cheri Cheng | Dec 01, 2014 12:40 PM ESTThe latest results from a Phase III trial testing the effects of a drug for a hard-to-treat type of multiple sclerosis (MS) are not promising, a new study reported.
-
Non-Invasive Diagnosis Of Bone Diseases Seen Possible In The First Human Trial
By Kamal Nayan | Dec 01, 2014 09:39 AM ESTFor the first time, a research has enabled detection of a genetic 'brittle bone' disease known as Osteogenesis Imperfecta (OI) by simply scanning a patient's limbs. Up until now, bone diseases have been diagnosed through X-rays, history of fractures and other clinical symptoms and, in the case of OI, genetic testing.
-
Stem Cells could be Key in Treating Parkinson’s
By Cheri Cheng | Nov 07, 2014 09:30 AM ESTIn a recent study, researchers used stem cells to treat Parkinson's disease in rats.
-
WHO: 1 Million Ebola vaccines by the End of 2015
By Cheri Cheng | Oct 24, 2014 09:57 AM EDTThe World Health Organization announced that for the first half of next year, there should be around 200,000 doses of the Ebola vaccine available.
-
Gene Therapy could be Safe and Effective in Treating Bubble Boy Syndrome
By Cheri Cheng | Oct 09, 2014 03:44 PM EDTAccording to a clinical trial, a form of gene therapy might be an effective and safe treatment option for patients with severe combined immune deficiency (SCID).
-
Pfizer Drug Effective for Patients with Rare Genetic Lung Cancer
By Cheri Cheng | Sep 27, 2014 10:24 AM EDTAccording to researchers, a Pfizer drug was effective in shrinking the tumor size in patients with a rare form of lung cancer.
-
NIH Gives $10.1 Million for Gender Equality in Trials
By Cheri Cheng | Sep 23, 2014 09:25 AM EDTThe NIH has distributed $10.2 million in additional funding for researchers to examine the role of gender in their trials.
-
10 American Participants Injected with Experimental Ebola Vaccine
By Cheri Cheng | Sep 17, 2014 09:28 AM EDTThe first two human trials for GlaxoSmithKline's experimental Ebola vaccine have started, according to health officials from the United States and the United Kingdom.
-
Two Trials Testing Apple’s HealthKit Are set to Start
By Cheri Cheng | Sep 15, 2014 09:16 AM EDTTwo hospitals in the United States are set to begin trials to test Apple's HealthKit.
-
Re-examining Data from Clinical Trials can Yield Different Results
By Cheri Cheng | Sep 10, 2014 12:15 PM EDTAccording to researchers from Stanford University School of Medicine, re-examining roughly one-third of the available randomized clinical trials resulted in very different results.
Most Popular News
- 1
Low-protein diet during pregnancy increases prostate cancer risk in offspring - 2
Feel lightheaded when standing up? You may have a greater risk of dementia - 3
Fitness trackers prove helpful in monitoring cancer patients - 4
Johnson & Johnson to pay Californian woman $417 million over talcum powder lawsuit - 5
Healthy beverage alternatives for the coffeeholics
